INVEGA^® SUSTENNA™ (paliperidone palmitate) Extended-Release Injectable Suspension for Acute and Maintenance Treatment of Schizophrenia

Five-day dosing regimen for Dacogen approved for myelodysplastic syndromes (MDS)

March 12, 2010

The FDA has approved a five-day dosing regimen for Dacogen (decitabine for injection, from Eisai) to treat patients with myelodysplastic syndromes (MDS).

FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates

March 11, 2010

The FDA has notified healthcare professionals and patients that at this point, the data that have been reviewed have not shown a clear connection between bisphosphonate use and a risk of atypical subtrochanteric femur fractures.

Trelstar 22.5mg approved for palliative treatment of prostate cancer

March 11, 2010

The FDA has approved Trelstar 22.5mg (triptorelin pamoate for injectable suspension, from Watson) for the palliative treatment of advanced prostate cancer.

FDA accepts NDA for lurasidone, a treatment for schizophrenia

March 11, 2010

Dainippon Sumitomo Pharma America announced that the FDA has accepted for filing the New Drug Application (NDA) submitted for lurasidone for the treatment of schizophrenia.

FDA warns of intravascular hemolysis risk with WinRho SDF

March 10, 2010

The FDA, Cangene, and Baxter have notified healthcare professionals that cases of intravascular hemolysis (IVH) and its complications have been reported in patients treated for immune thrombocytopenic purpura (ITP) with WinRho SDF [Rho(D) immune globulin IV (human)].

CELEXA ORAL SOLUTION

Central Nervous System > Mood disorders

Citalopram (as HBr) 2mg/mL; sugar- and alcohol-free; peppermint flavor; contains parabens.

FLINTSTONES GUMMIES

Nutrition > Vitamins/minerals/supplements

Vit. A 2000Units, pantothenic acid 5mg, Vit. B₆ 1mg, Vit. B₁₂ 5mcg, Vit. C 30mg, Vit. D 200Units, Vit. E 20Units, folic acid 200mcg, biotin 75mcg, choline 30mcg, inositol 20mcg, iodine 40mcg, zinc 2.5mg; per 2 gummies; assorted flavors and sours; contains fish gelatin, wheat.

GAS-X EXTRA STRENGTH CHEWABLES w. MAALOX

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

Simethicone 125mg, calcium carbonate 500mg; chew tabs; wildberry-flavor.

ONCASPAR

Neoplasms > Miscellaneous oncology agents

Pegaspargase 750 IU/mL; soln for IV or IM inj; preservative-free.

SYMMETREL SYRUP

Central Nervous System > Parkinsonism

Amantadine HCl 50mg/5mL; raspberry flavor.

This content has no related pharmacology notes. For a full list of pharmacology notes, please visit our
Pharmacology Notes section.

New Product: SAPHRIS^® (asenapine) Sublingual Tablets

March 09, 2010

CerefolinNAC^® (L-methylfolate [Metafolin], methylcobalamin, N-acetylcysteine) Caplets: A Novel Approach to Early Memory Loss

January 27, 2010

New Product: Zenpep™ (pancrelipase) Delayed-Release Capsules

January 13, 2010

INVEGA^® SUSTENNA™ (paliperidone palmitate) Extended-Release Injectable Suspension for Acute and Maintenance Treatment of Schizophrenia

January 05, 2010

FORTEO^® (teriparatide [rDNA origin] injection) for Use in Glucocorticoid-Induced Osteoporosis

December 17, 2009

Recommended Adult Immunization Schedule

March 02, 2010

This schedule indicates the recommended age groups and medical indications for routine administration of currently licensed vaccines for persons 19 years and older.

Antiemetic Medications

February 05, 2010

A list of drugs used for the treatment of nausea. The chart includes the formulations, strengths, and usual doses for each antiemetic drug product.

Catch-Up Immunization Schedule for Children

February 02, 2010

A catch-up immunization schedule for children 4 months to 18 years of age. The tables show minimum intervals between doses for children who have delayed immunizations.

Recommended Immunization Schedule for Ages 0 to 18 Years

January 21, 2010

This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines for children through age 18 years.

Mood Disorder Treatments

January 12, 2010

Mood disorder treatments for bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others.